Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Up 35.6% in February

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the target of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 16,137,050 shares, an increase of 35.6% from the January 29th total of 11,896,551 shares. Based on an average daily trading volume, of 11,713 shares, the short-interest ratio is currently 1,377.7 days. Based on an average daily trading volume, of 11,713 shares, the short-interest ratio is currently 1,377.7 days.

Genomma Lab Internacional Stock Performance

GNMLF stock remained flat at $1.00 during trading on Monday. The firm has a fifty day moving average price of $1.03 and a 200-day moving average price of $1.05. Genomma Lab Internacional has a 12-month low of $0.93 and a 12-month high of $1.43.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.